GleamWall
中文EN

SLN Silence Therapeutics plc

Pharmaceutical Preparations · Nasdaq · SEC CIK 1479615

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-98.2%
TTM net income YoY20.3%
TTM EPS YoY22.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin95.0%
Operating margin-12,343.6%
Net margin-11,276.5%
FCF margin-9,681.6%
EBITDA margin-12,279.2%

Returns

ROE-35.6%
ROA-24.0%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets23.6%
Debt / equity0.00x
Current ratio23.94x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.86x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$559,000$43.26M
Cost of revenue$215,000$11.81M
Gross profit$344,000$31.45M
R&D expense$67.75M$67.88M
SG&A expense$22.34M$26.88M
Operating income-$91.08M-$63.32M
Pretax income-$88.60M-$44.46M
Income tax$11,000$845,000
Net income-$88.61M-$45.31M
EBITDA-$90.77M-$62.98M
EPS (basic)-0.63-0.33
EPS (diluted)-0.63-0.33
Weighted avg. shares (diluted)141.69M138.75M
Balance sheet
Cash & equivalents$11.28M$121.33M
Short-term investments$73.84M$26.00M
Receivables$0$972,000
Current assets$118.66M$187.37M
PP&E, net$1.58M$1.82M
Goodwill$10.62M$9.39M
Intangibles$288,000$312,000
Total assets$131.44M$202.63M
Current liabilities$13.61M$16.82M
Total liabilities$69.14M$68.61M
Shareholders' equity$62.30M$134.02M
Shares outstanding141.70M141.67M
Cash flow statement
Operating cash flow-$62.27M-$67.64M
Capital expenditure$55,000$211,000
Free cash flow-$62.33M-$67.85M
Investing cash flow-$47.99M-$21.97M
Financing cash flow$15,000$142.09M
Depreciation & amortization$312,000$336,000
Stock-based compensation$8.07M$16.31M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.